How Many Doses Are in a Semaglutide Pen?

Last reviewed: June 5, 2026

Last updated: June 5, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide pens are designed as multi-dose delivery systems that provide a full month of weekly injections for most patients entering a weight loss protocol. Understanding how many doses your pen contains and how the dosing schedule works helps you plan your treatment timeline and manage expectations for dose escalation during your first several months of therapy.

How Many Weekly Doses Come in a Semaglutide Pen

A standard semaglutide pen typically contains enough medication for approximately four weekly doses, which covers one full month of treatment. Each injection delivers a specific amount measured in milligrams, and your starting dose is usually lower than your maintenance dose to allow your body to adjust gradually. The exact number of pens you receive depends on your prescribed dosing protocol and whether you begin at the lowest starting dose or a higher introductory level based on your individual health profile.

PlexusDx delivers compounded semaglutide injections from licensed 503A compounding pharmacies with monthly flat-rate pricing that does not increase as your dose escalates. This means you can move through your dose titration schedule—increasing your weekly injection amount every one to four weeks—without paying more as you progress toward your target therapeutic dose. Your dose may need to go up, but your price stays at the same $149 per month baseline.

Understanding Semaglutide Dose Titration Schedules

Most semaglutide treatment plans follow a dose escalation protocol that begins with a lower starting dose and gradually increases over 8 to 16 weeks until reaching an effective maintenance level. A typical titration might begin at 0.25 mg once weekly, then move to 0.5 mg, 1.0 mg, 1.7 mg, and potentially 2.4 mg depending on your clinical response and tolerance. Each step in this progression is spaced weeks apart to give your body time to adapt and minimize side effects like nausea or gastrointestinal discomfort.

Your individual titration timeline depends on how well you tolerate each dose level and how your body responds to the medication. Some patients remain at a lower maintenance dose that produces the weight loss and metabolic benefits they need, while others benefit from advancing to higher concentrations. PlexusDx works with licensed compounding pharmacies to ensure your dose adjustments are timed appropriately and your monthly supply matches your current protocol stage.

Compounded vs. Branded Semaglutide Pen Differences

Branded semaglutide pens (such as Ozempic or Wegovy) come prefilled with fixed doses and require a new pen for each dose level change, which can create gaps in treatment and higher out-of-pocket costs for patients without insurance coverage. PlexusDx compounded semaglutide from licensed 503A pharmacies offers flexibility because the concentration and volume can be customized to match your current dose without changing the delivery device. This approach reduces waste and simplifies your supply management as you move through your titration schedule.

Compounded semaglutide is not FDA-approved in the way branded formulations are, but it is manufactured by licensed 503A compounding pharmacies that follow strict pharmaceutical standards and quality controls. Many patients choose compounded options because they provide consistent access without insurance barriers, maintain affordability throughout dose escalation, and eliminate monthly price increases tied to higher therapeutic doses.

Planning Your Monthly Supply and Dose Progression

When you begin semaglutide therapy with PlexusDx, your first month's supply typically contains the doses needed for your initial four-week titration phase. As you progress through your dose escalation schedule, your monthly refills continue to arrive on the same cycle regardless of whether you remain at your current dose or advance to a higher one. This predictable monthly delivery pattern helps you stay consistent with your treatment without worrying about running out or managing multiple prescription refills.

If you are taking the Precision Peptide Genetic Test offered by PlexusDx, genetic insights into your GLP1R, GIPR, FTO, and MC4R variants can help predict how your body may respond to semaglutide dosing and support personalized dose recommendations. Understanding your genetic pathway predispositions allows your care team to anticipate whether you might benefit from a faster or slower titration schedule, or whether you may reach therapeutic benefit at a lower or higher maintenance dose than average.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How long does one semaglutide pen last if I take it weekly?

A standard semaglutide pen contains approximately four weeks of weekly injections, making it a one-month supply for most patients. Depending on your dose strength and individual titration schedule, you may use one pen per month or potentially transition to a new pen mid-month if your dose is increased.

Will I need a new pen every time my dose increases?

With compounded semaglutide from PlexusDx licensed 503A pharmacies, dose increases do not require a new pen device—your prescription is adjusted within the same delivery system. This differs from some branded pens that require a new device for each dose level and can reduce treatment gaps and supply complications.

Does PlexusDx charge more if my dose goes higher?

No. PlexusDx offers flat monthly pricing for compounded semaglutide starting at $149 per month regardless of your current dose level. Your dose may need to go up over your first few months of therapy, but your monthly price remains the same—no increases as you titrate toward your therapeutic target.

What if I cannot tolerate a dose increase—can I stay on a lower dose?

Yes. Many patients find that a lower maintenance dose provides the weight loss and appetite control benefits they need without advancing to the highest available strength.

How does the Precision Peptide Genetic Test help with semaglutide dosing?

The PlexusDx Precision Peptide Genetic Test maps genetic variants in GLP1R, GIPR, FTO, and MC4R that influence how your body responds to GLP-1 medications.

Related Reading

• Medvi Semaglutide
• Bioverse Semaglutide
• Ro Semaglutide
• Mochi Semaglutide

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.